Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
Go back to Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 290.71 +3.12 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $287.59 | 52 Week High | $139.79 | |||
| Open | $291.02 | 52 Week Low | $82.07 | |||
| Day High | $294.61 | P/E | 676.07 | |||
| Day Low | $282.25 | EPS | $0.43 | |||
| Volume | 231,199 | |||||
| (NYSE: PTHS) | Delayed: 25.82 -0.29 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.11 | 52 Week High | $ | |||
| Open | $26.59 | 52 Week Low | $ | |||
| Day High | $28.14 | P/E | N/A | |||
| Day Low | $25.74 | EPS | $ | |||
| Volume | 17,786 | |||||
